Programme Coordinator
Prof. Pavel Martásek, MD, DSc (CV pdf)
email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Programme Description
This programme includes a spectrum of projects covering reproductive medicine, diabetic complications, autoimmune and selected tumour diseases, inherited metabolic disorders, and study of heme pathology and of the effect of lack or excess of gaseous signalling molecules, The unifying element of all the projects is the study of the pathological condition of a cell, that is, finding out the causes of this condition, profiling the expression of the chosen genes, detecting changes in the localization and modification of the chosen proteins and identifying other molecules that relate to the induction of the pathology, furthering the development of new procedures for the prevention of the disease and creating new methods and diagnostics for monitoring the process of the disease and tools for the molecular therapy of the accompanying pathological condition.
Research Outcomes
Application Potential
The programme has a notable application potential, namely in medicine. Insight into the preventive possibilities will impact the health and quality of life of large population subgroups. The recent clinical practice will be directly influenced by novel diagnostic approaches, with elucidation of a novel generation of biomarkers, preparation of newly designed diagnostic kits, and later with design of novel treatment modalities. The future of therapeutic interventions lies in personalized therapy; the application outputs of the research programme unequivocally accent this direction.
Photo Gallery


Assisted reproduction
Monoclonal antibodies against acrosomal proteins used for their identification and for diagnostics of sperm quality – utilization in the laboratories of assisted reproduction
Normal spermiogram Pathological spermiogram

Model of the active centre of enzyme NO-synthase
Precise knowledge of its structure helps design drugs capable of e.g. targeted blockage of the access to the active centre, and in this way impact the enzyme function
